Combo Therapy Boosts Survival for Advanced Colon Cancer
WEDNESDAY, May 29, 2024 (HealthDay News) — People battling advanced colon cancers might have a new treatment option that could extend their survival, a new trial finds. A combination of two experimental immunotherapy drugs plus standard chemotherapy led to a median 19.7 month survival for patients, compared to the medianContinue Reading